Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Trial of Treatment of Advanced-Stage Anaplastic Large Cell Lymphoma (ALCL) With Standard APO (Doxorubicin, Prednisone, Vincristine) Versus Consolidation With a Regimen Including Vinblastine

NCT00059839 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00059839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00059839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Trial of Treatment of Advanced-Stage Anaplastic Large Cell Lymphoma (ALCL) With Standard APO (Doxorubicin, Prednisone, Vincristine) Versus Consolidation With a Regimen Including Vinblastine
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2003
Completion date
July 31, 2014
Enrollment
129 (actual)
Sites
159

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma